[go: up one dir, main page]

NZ334487A - Use of somatostatin type-5 receptor agonist for treating hyperamylinemia - Google Patents

Use of somatostatin type-5 receptor agonist for treating hyperamylinemia

Info

Publication number
NZ334487A
NZ334487A NZ334487A NZ33448796A NZ334487A NZ 334487 A NZ334487 A NZ 334487A NZ 334487 A NZ334487 A NZ 334487A NZ 33448796 A NZ33448796 A NZ 33448796A NZ 334487 A NZ334487 A NZ 334487A
Authority
NZ
New Zealand
Prior art keywords
receptor agonist
somatostatin type
hyperamylinemia
treating
treating hyperamylinemia
Prior art date
Application number
NZ334487A
Inventor
Simon Jon Dunmore
Michelle Davenport
Michael Anthony Cawthorne
Original Assignee
Univ Buckingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/440,061 external-priority patent/US5763200A/en
Application filed by Univ Buckingham filed Critical Univ Buckingham
Publication of NZ334487A publication Critical patent/NZ334487A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Use of a somatostatin type-5 receptor agonist which is a compound which is more selective for SSTR-5 than for SSTR-2 for treating hyperamylinemia which are effective in inhibiting release of amylin from pancreas cells.
NZ334487A 1995-05-12 1996-05-11 Use of somatostatin type-5 receptor agonist for treating hyperamylinemia NZ334487A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/440,061 US5763200A (en) 1995-05-12 1995-05-12 Inhibition of amylin release
NZ308105A NZ308105A (en) 1995-05-12 1996-05-11 Inhibition of amylin release with somatostatin type-5 receptor (sstr-5), determination of amylin release inhibition

Publications (1)

Publication Number Publication Date
NZ334487A true NZ334487A (en) 2000-07-28

Family

ID=26651721

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ334487A NZ334487A (en) 1995-05-12 1996-05-11 Use of somatostatin type-5 receptor agonist for treating hyperamylinemia

Country Status (1)

Country Link
NZ (1) NZ334487A (en)

Similar Documents

Publication Publication Date Title
AU2455199A (en) Compositions and methods for regulated secretion from neuroendocrine cell lines
NZ503033A (en) Inhibition of complement activation using anti-properdin agents
ZA977086B (en) NAALADase inhibitors.
TW335354B (en) Apparatus for mounting a binding to a snowboard
UA29484C2 (en) Method for treating myocarditis, cardiomyopathy, endocarditis, and pericarditis
HU9700368D0 (en) Treating of ii-type diabetes mellitus with amylin-agonists
GB9705371D0 (en) Control of data transfer and distributed data processing
PL323381A1 (en) Rotamase enzymatic activity inhibitors
HUP0004271A3 (en) Compositions comprising amylin or amylin agonist for treating obesity
AU4681997A (en) System and method for automatic bucket loading using force vectors
HK1041210A1 (en) Compositions and methods for regulating lymphocyte activation
IL125588A0 (en) Device and method for debugging systems controlled by microprocessors
ZA972000B (en) Inhibition of proliferation of cells.
GB2332338B (en) System and method for marking and screening calls e.g telephone calls
CY2483B1 (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation.
SG54384A1 (en) Non-destructive interconnect system for semiconductor devices and a carrier assembly for use therewith
GB2297193B (en) Apparatus for automatically replenishing chips
NZ334487A (en) Use of somatostatin type-5 receptor agonist for treating hyperamylinemia
MX9708740A (en) Inhibition of amylin release.
EP0858262A4 (en) Thrombin inhibitors
SG54130A1 (en) Staining technique for semiconductor device for sem exposure
MY113476A (en) A method for templateless foundation installation
EP0868197A4 (en)
AU6868898A (en) N-methyl-d-aspartate receptor channel blockers and method for identifying such
ES2162441T3 (en) USE OF A VULGARIS ALCHEMILLA EXTRACT.